BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paradigms Foundation
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261203T134500
DTEND;TZID=Europe/Paris:20261203T144500
DTSTAMP:20260922T100812Z
CREATED:20260922T100423Z
LAST-MODIFIED:20260922T100812Z
UID:14932-1796305500-1796309100@paradigms.foundation
SUMMARY:Paradigms pre-MENACTRIMS Symposium 2026
DESCRIPTION:Intercontinental Festival City\, Dubai\, United Arab Emirates \n\n\n\nAdvancing Multiple Sclerosis Care Across the Middle East and North Africa\n\n\n\nMENACTRIMS\, the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis\, is a regional scientific organisation dedicated to advancing knowledge\, research\, education and clinical care in multiple sclerosis (MS) and related neuroimmunological disorders across the Middle East and North Africa. \n\n\n\nMENACTRIMS brings together neurologists\, researchers\, healthcare professionals and experts from across the region and internationally\, creating a platform for scientific exchange\, collaboration and education. \n\n\n\nThrough its scientific and educational activities\, MENACTRIMS aims to support healthcare professionals in navigating a rapidly evolving MS landscape and translating advances in research\, diagnosis\, monitoring and treatment into meaningful improvements in clinical practice. \n\n\n\nParadigMS Pre-MENACTRIMS Symposium\n\n\n\nFrom Biomarkers to Better Decisions in Multiple Sclerosis\n\n\n\nHeld in conjunction with MENACTRIMS\, the ParadigMS Pre-MENACTRIMS Symposium is a focused scientific and educational meeting bringing together experts in multiple sclerosis to explore how emerging tools and biomarkers can support more personalised approaches to MS management. \n\n\n\nAs the MS treatment landscape becomes increasingly complex\, clinicians have access to a growing range of information beyond conventional clinical assessment. Advanced imaging\, fluid biomarkers and digital technologies offer new possibilities for detecting disease activity\, evaluating treatment response and identifying patients who may be at greater risk of progression. \n\n\n\nThe symposium will examine how these developments can move from scientific promise towards meaningful application in everyday clinical practice. \n\n\n\nKey Takeaways\n\n\n\n\nHow technological\, imaging and fluid biomarkers may contribute to more personalised MS treatment decisions.\n\n\n\nWhich biomarker signals may help identify subclinical disease activity\, treatment response and progression risk.\n\n\n\nThe role of imaging biomarkers in monitoring inflammatory activity\, neurodegeneration and smouldering disease.\n\n\n\nHow serum neurofilament light chain and other fluid biomarkers may be interpreted in clinical practice.\n\n\n\nHow digital and wearable technologies may complement clinic-based assessment by capturing real-world function over time.\n\n\n\nThe key limitations\, confounding factors and standardisation issues affecting biomarker interpretation.\n\n\n\nHow biomarker information can be integrated with clinical judgement\, MRI findings\, patient characteristics and treatment goals.\n\n\n\nWhich biomarkers are closest to routine clinical implementation and which remain primarily investigational.\n\n\n\nHow biomarker strategies may be adapted to different healthcare systems and levels of resource availability.\n\n\n\n\nWith thanks to our sponsor\, who supports this event without any involvement in the elaboration of the presentations.
URL:https://paradigms.foundation/event/paradigms-pre-menactrims-symposium-2026/
ATTACH;FMTTYPE=image/png:https://paradigms.foundation/wp-content/uploads/2026/09/Banner-MENACTRIMS-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261221T170000
DTEND;TZID=Europe/Paris:20261221T180000
DTSTAMP:20260922T101743Z
CREATED:20260902T100219Z
LAST-MODIFIED:20260922T101743Z
UID:14751-1797872400-1797876000@paradigms.foundation
SUMMARY:Live Webinar on the new therapies in Myasthenia Gravis
DESCRIPTION:Live webinar | Monday 21 December 2026 | 17:00–18:00 CET \n\n\n\nJoin this live ParadigMS webinar for an expert-led discussion on new and emerging therapies in myasthenia gravis\, with a focus on their relevance for clinical practice. \n\n\n\nDuring this one-hour session\, Andrew Chan\, Maura Pugliatti and Celia Oreja-Guevara will review current developments and discuss how advances in treatment may influence therapeutic decision-making. \n\n\n\nThe session will bring together leading experts to discuss current clinical considerations and provide practical insights relevant to neurologists and healthcare professionals involved in MS care. \n\n\n\nRegister to join the live webinar and hear perspectives from leading neurology experts. \n\n\n\nKey Highlights\n\n\n\nThe session will provide an expert overview of the changing treatment landscape in myasthenia gravis and its implications for clinical practice. Participants will have the opportunity to: \n\n\n\n\nExplore recent developments in therapies for myasthenia gravis.\n\n\n\nReview the evolving therapeutic landscape.\n\n\n\nConsider the clinical relevance of new treatment options.\n\n\n\nHear expert perspectives on treatment decision-making.\n\n\n\nJoin the discussion during the live session.\n\n\n\n\nMore information & Learning Objectives to come soon\n\n\n\nRegister\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\nLanguage\n\n\n\nThe session will be held in English with translated auto-captions into many languages (offered by Zoom platform). \n\n\n\nWho should attend?\n\n\n\n\nNeurologists and paediatric neurologists with an interest in Multiple Sclerosis\n\n\n\nMS specialists and neurologists in training\n\n\n\nNurses and other healthcare professionals involved in MS care\n\n\n\nHealthcare professionals involved in the diagnosis or management of paediatric demyelinating disorders\n\n\n\n\nQuestions and comments\n\n\n\nShould you have specific questions\, you would like to see discussed\, please share them with learning@paradigms.foundation now\, so the speakers could relate to them in their presentations.  \n\n\n\nYou will also have the opportunity to ask questions in person and participate in discussion during the webinar and the Q&A session. \n\n\n\nTechnology used\n\n\n\nThe webinar takes place via Zoom\, you will receive connection details upon registration. \n\n\n\nDate and time\n\n\n\nDate: Monday 21 December 2026Time: 17:00-18:00 CETFormat: Live online webinarDuration: 60 minutes \n\n\n\nSpeakers\n\n\n\nFind out more about the speakers: \n\n\n\n\n\n\n\nCelia Oreja-Guevara \n\n\n\nVice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos\, Madrid \n\n\n\n\n\n\n\nAndrew Chan \n\n\n\nHead of the Medical Division Neuro at the Bern University Hospital \n\n\n\n\n\n\n\nMaura Pugliatti \n\n\n\nProfessor of Neurology at the University of Ferrara \n\n\n\nFunding\n\n\n\nThis webinar is funded with ParadigMS own funds. No other sponsors have been invited to support this webinar.
URL:https://paradigms.foundation/event/new-therapies-in-myasthenia-gravis/
ATTACH;FMTTYPE=image/png:https://paradigms.foundation/wp-content/uploads/2026/09/New-therapies-in-MG.png
END:VEVENT
END:VCALENDAR